
Game-changer: 6-monthly anti-HIV jab could end Aids in South Africa by 2032
A modelling study released in March gives a clue at which price the six-monthly anti-HIV jab, lenacapavir, would be worth the health department's while. The health department needs to step in, as the US government is unlikely to stick to a December …